Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 8 studies | 34% ± 12% | |
endothelial cell | 5 studies | 25% ± 8% | |
astrocyte | 5 studies | 24% ± 8% | |
glutamatergic neuron | 4 studies | 29% ± 8% | |
fibroblast | 4 studies | 18% ± 1% | |
GABAergic neuron | 3 studies | 28% ± 2% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 6% | |
adipocyte | 3 studies | 19% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2772.32 | 245 / 245 | 100% | 10.57 | 500 / 502 |
esophagus | 100% | 2850.38 | 1443 / 1445 | 99% | 10.62 | 182 / 183 |
intestine | 100% | 2996.99 | 965 / 966 | 98% | 6.85 | 518 / 527 |
ovary | 100% | 3984.72 | 180 / 180 | 97% | 6.98 | 418 / 430 |
kidney | 100% | 1867.58 | 89 / 89 | 97% | 9.48 | 875 / 901 |
brain | 98% | 1181.24 | 2589 / 2642 | 99% | 12.73 | 697 / 705 |
pancreas | 98% | 1341.91 | 323 / 328 | 98% | 9.66 | 175 / 178 |
stomach | 100% | 2107.05 | 359 / 359 | 96% | 7.80 | 275 / 286 |
uterus | 100% | 3492.84 | 170 / 170 | 96% | 7.60 | 440 / 459 |
bladder | 100% | 3016.86 | 21 / 21 | 95% | 6.56 | 479 / 504 |
lung | 100% | 4039.91 | 577 / 578 | 93% | 6.96 | 1077 / 1155 |
thymus | 100% | 4633.80 | 653 / 653 | 92% | 20.57 | 559 / 605 |
breast | 100% | 2689.30 | 459 / 459 | 92% | 8.51 | 1032 / 1118 |
adrenal gland | 97% | 1393.84 | 250 / 258 | 92% | 6.42 | 211 / 230 |
skin | 100% | 4103.31 | 1808 / 1809 | 89% | 6.78 | 418 / 472 |
liver | 89% | 854.93 | 201 / 226 | 79% | 4.31 | 321 / 406 |
adipose | 100% | 2806.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4816.32 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.81 | 1 / 1 |
muscle | 99% | 1578.84 | 796 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 2713.16 | 847 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 5.70 | 41 / 45 |
spleen | 84% | 821.18 | 202 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 4.36 | 63 / 80 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.09 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
Gene name | PTPN21 |
Protein name | Protein tyrosine phosphatase non-receptor type 21 DJ1175B15.2 (Protein tyrosine phosphatase, non-receptor type 21) Tyrosine-protein phosphatase non-receptor type 21 (EC 3.1.3.48) (Protein-tyrosine phosphatase D1) |
Synonyms | PTPD1 |
Description | |
Accessions | ENST00000328736.7 ENST00000536337.5 Q16825 ENST00000553531.1 H0YJ59 G3V1Q9 Q8WX29 ENST00000555243.1 G3V3S6 ENST00000556564.6 |